Browsing by Subject "C07K 2317/34"
Now showing items 1-9 of 9
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-08-13)Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-07-21)Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-05-25)Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-02-03)Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2006-10-31)Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-07-31)This disclosure pertains to isolated antibodies or antigen binding fragments thereof that specifically bind to the 3ABC non-structural protein of Foot-and-Mouth Disease virus (FMDV), wherein the antibodies or antigen binding ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-07-07)The disclosed invention relates to the use of perlecan domain V (DV) for the treatment of stroke, traumatic brain injury (TBI) or spinal cord injuries (SCI). In certain embodiments, fusion proteins of DV can be used for ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 9/20/2022)The present invention provides methods and compositions to reduce binding of fibrinogen to the ClfA in a gram positive bacterial infections using monoclonal antibody, a polyclonal antibody, an antigen-binding antibody ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-07-03)Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...